546.76
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TMO Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$542.83
Aprire:
$541.2
Volume 24 ore:
2.11M
Relative Volume:
1.06
Capitalizzazione di mercato:
$205.42B
Reddito:
$44.56B
Utile/perdita netta:
$6.73B
Rapporto P/E:
30.82
EPS:
17.7391
Flusso di cassa netto:
$6.29B
1 W Prestazione:
-6.02%
1M Prestazione:
-11.65%
6M Prestazione:
+18.68%
1 anno Prestazione:
-4.32%
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Nome
Thermo Fisher Scientific Inc
Settore
Industria
Telefono
(781) 622-1000
Indirizzo
168 THIRD AVENUE, WALTHAM, MA
Compare TMO vs DHR, IDXX, A, IQV
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
TMO
Thermo Fisher Scientific Inc
|
546.76 | 203.95B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
216.66 | 153.12B | 24.57B | 3.60B | 5.25B | 5.0475 |
|
IDXX
Idexx Laboratories Inc
|
639.79 | 51.47B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
127.50 | 36.74B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
IQV
Iqvia Holdings Inc
|
192.67 | 31.80B | 15.90B | 1.28B | 2.21B | 7.2842 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-11 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-12-09 | Iniziato | Goldman | Buy |
| 2025-12-08 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-12-02 | Ripresa | Morgan Stanley | Overweight |
| 2025-12-01 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2025-09-11 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2025-08-19 | Iniziato | William Blair | Outperform |
| 2025-07-24 | Downgrade | HSBC Securities | Buy → Hold |
| 2025-07-11 | Aggiornamento | Scotiabank | Sector Perform → Sector Outperform |
| 2025-07-09 | Downgrade | UBS | Buy → Neutral |
| 2025-01-10 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | Iniziato | Scotiabank | Sector Perform |
| 2024-10-14 | Iniziato | Redburn Atlantic | Buy |
| 2024-10-01 | Iniziato | Stephens | Overweight |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-03-18 | Ripresa | Citigroup | Neutral |
| 2024-01-24 | Downgrade | Barclays | Overweight → Equal Weight |
| 2024-01-08 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | Iniziato | HSBC Securities | Buy |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-10-26 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | Iniziato | Bernstein | Outperform |
| 2023-09-06 | Ripresa | Citigroup | Buy |
| 2023-07-19 | Iniziato | Raymond James | Outperform |
| 2023-07-19 | Reiterato | Robert W. Baird | Outperform |
| 2023-07-13 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | Reiterato | Barclays | Overweight |
| 2022-12-14 | Iniziato | Deutsche Bank | Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-10-27 | Downgrade | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Iniziato | Credit Suisse | Neutral |
| 2022-04-25 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | Ripresa | Barclays | Overweight |
| 2021-10-20 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-07-16 | Iniziato | The Benchmark Company | Buy |
| 2021-03-18 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Iniziato | Barclays | Overweight |
| 2021-01-08 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | Downgrade | Citigroup | Buy → Neutral |
| 2020-12-02 | Iniziato | Goldman | Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Iniziato | Atlantic Equities | Overweight |
| 2020-09-14 | Iniziato | Morgan Stanley | Overweight |
| 2020-08-20 | Ripresa | JP Morgan | Overweight |
| 2020-07-15 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2020-07-07 | Reiterato | Needham | Buy |
| 2020-04-23 | Reiterato | Needham | Buy |
| 2020-01-31 | Reiterato | Needham | Buy |
| 2020-01-22 | Iniziato | Credit Suisse | Neutral |
| 2020-01-08 | Iniziato | Wells Fargo | Equal Weight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-07-25 | Reiterato | Needham | Buy |
| 2019-07-16 | Downgrade | Needham | Strong Buy → Buy |
| 2019-05-30 | Iniziato | Wolfe Research | Outperform |
| 2019-05-23 | Reiterato | Needham | Strong Buy |
| 2019-04-22 | Reiterato | Needham | Strong Buy |
| 2019-04-16 | Reiterato | BofA/Merrill | Buy |
Mostra tutto
Thermo Fisher Scientific Inc Borsa (TMO) Ultime notizie
Edgemoor Investment Advisors Inc. Sells 5,621 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Prices $3.8 Billion Senior Notes - marketscreener.com
Midwest Trust Co Has $43.26 Million Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Compagnie Lombard Odier SCmA Has $142.48 Million Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher (TMO) Prices $3.8 Billion Debt Offering - GuruFocus
Thermo Fisher prices $3.8B note offering - MSN
Thermo Fisher Scientific Prices Offering of USD-Denominated Senior Notes - marketscreener.com
Thermo Fisher prices $3.8 billion notes offering for Clario acquisition - Investing.com
Thermo Fisher Scientific says prices $3.8 bln offering of USD-denominated senior notes - marketscreener.com
Thermo Fisher Scientific Says Prices $3.8 Bln Offering Of USD-Denominated Senior Notes - TradingView
Thermo Fisher Scientific Inc files for four-part senior notes offering size not disclosed - marketscreener.com
This Top Artificial Intelligence (AI) Stock Could Have More Upside in 2026 - The Motley Fool
Exosomes Market to See Thriving Worldwide | Thermo Fisher Scientific, Inc., Bio-Techne - openPR.com
Thermo Fisher stock holds near $543 after Thursday slide as traders size up layoffs notice, data week ahead - TechStock²
Taking A Fresh Look At Thermo Fisher Scientific (TMO) Valuation After Recent Share Price Weakness - simplywall.st
Thermo Fisher Q4 Beat Highlights Bioproduction Strength And Product-Led Growth Shift - Yahoo Finance
Thermo Fisher stock price today: TMO nudges higher after Thursday drop as investors eye next week’s data - TechStock²
How Is The Market Feeling About Thermo Fisher Scientific Inc? - Benzinga
Will Thermo Fisher Scientific (TMO) Benefit from Favorable Trends in the Market? - Insider Monkey
Thermo Fisher Scientific Inc. $TMO Shares Sold by Portside Wealth Group LLC - MarketBeat
Thermo Fisher Resets Footprint With Franklin Closure And US$9b Clario Deal - simplywall.st
Thermo Fisher, Charles River workforce cuts; WuXi signs contract with Vertex - Endpoints News
OpenAI Unveils Platform to Help Companies Deploy ‘AI Coworkers’ - bloomberg.com
5 Insightful Analyst Questions From Thermo Fisher's Q4 Earnings Call - Finviz
3 Reasons to Sell TMO and 1 Stock to Buy Instead - Finviz
5 Insightful Analyst Questions From Thermo Fisher’s Q4 Earnings Call - TradingView
The Zacks Analyst Blog Highlights Alphabet, Apple, Thermo Fisher Scientific and New England Realty Associates - Yahoo Finance
Thermo Fisher to Close Franklin, Mass. Site, Cut Up to 80 Jobs - Contract Pharma
Thermo Fisher Stock: Can This Life-Science Giant Still Outperform After Its Rebound? - AD HOC NEWS
Premier Path Wealth Partners LLC Has $2.21 Million Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Inc. $TMO Shares Sold by Alta Capital Management LLC - MarketBeat
Thermo Fisher Scientific Inc. $TMO Shares Sold by Hantz Financial Services Inc. - MarketBeat
Thermo Fisher Scientific launches kit to simplify liver cell gene expression and help advance early-stage drug discovery - SelectScience
Thermo Fisher Stock: Quiet Giant Or The Next Breakout In Life Sciences? - AD HOC NEWS
Top Analyst Reports for Alphabet, Apple & Thermo Fisher - Yahoo Finance
Major biotech company to lay off dozens of employees, close Mass. facility - MassLive.com
Thermo Fisher to close Franklin MA plant; more than 100 jobs affected - Milford Daily News
OTC/DTC Infectious Disease Diagnostics Research Report 2026: Market Strategies, Trends, and Forecasts 2025-2029 - GlobeNewswire Inc.
AGF Management Ltd. Sells 118,109 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Earnings call transcript: Thermo Fisher Q4 2025 earnings beat forecasts - Investing.com
Strengthening Families & Communities LLC Purchases 4,825 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thrivent Financial for Lutherans Sells 13,573 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Peterson Wealth Services Increases Stock Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Earnings call transcript: Thermo Fisher Q4 2025 earnings beat forecasts By Investing.com - Investing.com India
Thermo Fisher Scientific Inc. $TMO Shares Acquired by Jones Financial Companies Lllp - MarketBeat
Pharmacogenomics Market Is Booming Worldwide 2026-2033 | - openPR.com
Synthetic Biology Market Future Business Opportunities - openPR.com
Thermo Fisher Scientific (TMO) Is Down 7.2% After Stronger‑Than‑Expected 2025 Earnings Beat ExpectationsWhat's Changed - simplywall.st
Thermo Fisher Stock: Can A Quiet Healthcare Giant Still Beat The Market? - AD HOC NEWS
Here's How Much You Would Have Made Owning Thermo Fisher Scientific Stock In The Last 15 Years - Sahm
Layoff notices hit Massachusetts hard as 260 to lose jobs - Boston Herald
Thermo Fisher Scientific Inc Azioni (TMO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):